Sign in
4

Changes in Ownership

Traws Pharma, Inc. Filed Acc 0001179110-20-006358

Chief Financial Officer bought 21,000 shares at $0.36 ($7,560)

From the SEC's structured data for this filing

Trades in this filing

Guerin Mark Patrick · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-05-19 Purchase : show line 1 in the form +21,000 $0.36 $7,560 108,844 D
Open-market purchases · 21,000 sh · avg $0.36 · $7,560
Loading xslF345X03/edgar.xml…